Neena Kadaba

Director/Board Member at Eyevensys SAS

Finance

Consumer Services

Commercial Services

Profile

Neena Kadaba is currently a Director at Eyevensys SAS since 2020.
Prior to this, she worked as a Partner at Mission Bay Capital Management, Inc. from 2014 to 2015.
Dr. Kadaba completed her undergraduate and graduate degrees from Massachusetts Institute of Technology in 2003 and received her doctorate degree from California Institute of Technology in 2008.

Neena Kadaba active positions

Companies	Position	Start
Eyevensys SAS Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.	Director/Board Member	08/01/2020

All active positions of Neena Kadaba

Former positions of Neena Kadaba

Companies	Position	End
Mission Bay Capital Management, Inc. Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California.	Private Equity Investor	31/12/2015

See the detail of Neena Kadaba's experience

Training of Neena Kadaba

Massachusetts Institute of Technology	Graduate Degree
California Institute of Technology	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Neena Kadaba's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Mission Bay Capital Management, Inc. Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California.	Finance
Eyevensys SAS Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.	Commercial Services